Study of Oral LBH589 in Adult Participants With Refractory/Resistant Cutaneous T-Cell Lymphoma (CTCL)

NYU Clinical Cancer Center, New York

Our Lady of Mercy Medical Center/Comprehensive Cancer Center, The Bronx

Roswell Park Cancer Institute, Buffalo

University of Pittsburg Medical Center, Pittsburgh

Wake University Health Sciences, Winston-Salem

Medical College of Georgia, Augusta

Florida Academic Dermatology Centers, Miami

University of Alabama at Birmingham/ The Kirklin Clinic, Birmingham

The Jones Clinic, Germantown

Rush Presbyterian Hospital/St. Luke's Medical Center, Chicago

St. Louis University Cancer Cennter, St Louis

Nebraska Medical Center, Omaha

University of Oklahoma-Tulsa, Tulsa

MD Anderson Cancer Center/University of Texas, Houston

University of Colorado Health Sciences Center/Anschutz Cancer Pavillion, Aurora

UCLA Medical Center School of Medicine/ Dpt of Hematology-Oncology, Los Angeles

Craig Okada, Portland

Seattle Cancer Care Alliance, Seattle